Phase II Study of Vincristine Sulfate Liposome Injection (Marqibo) and Rituximab for Patients With Relapsed and Refractory Diffuse Large B-Cell Lymphoma or Mantle Cell Lymphoma in Need of Palliative Therapy
Clinical Lymphoma, Myeloma and Leukemia - United States
doi 10.1016/j.clml.2013.09.009
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2014
Authors
Publisher
Elsevier BV